{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T22:31:22Z","timestamp":1720564282319},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.mehy.2018.05.004","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T06:05:55Z","timestamp":1526969155000},"page":"139-140","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Two for one: Viral helicases as an ideal target for HIV and HCV co-infection"],"prefix":"10.1016","volume":"116","author":[{"given":"Muhammad Faraz","family":"Anwar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamshad","family":"Zarina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Hani","family":"Abidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mehy.2018.05.004_b0005","first-page":"1","article-title":"The hepatitis C virus NS3 protein: a model RNA helicase and potential drug target","volume":"9","author":"Frick","year":"2007","journal-title":"Curr Issues Mol Biol"},{"issue":"2","key":"10.1016\/j.mehy.2018.05.004_b0010","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.virusres.2012.06.022","article-title":"Cellular RNA helicases and HIV-1: insights from genome-wide, proteomic, and molecular studies","volume":"171","author":"Chen","year":"2013","journal-title":"Virus Res"},{"issue":"15","key":"10.1016\/j.mehy.2018.05.004_b0015","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1093\/nar\/gkl398","article-title":"Role of RNA helicases in HIV-1 replication","volume":"34","author":"Jeang","year":"2006","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.mehy.2018.05.004_b0020","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1099\/vir.0.000092","article-title":"Identification of RNA helicases in human immunodeficiency virus 1 (HIV-1) replication\u2013a targeted small interfering RNA library screen using pseudotyped and WT HIV-1","volume":"96","author":"Williams","year":"2015","journal-title":"J Gen Virol"},{"issue":"5","key":"10.1016\/j.mehy.2018.05.004_b0025","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1247\/csf.15.295","article-title":"Fluoroquinolones protect the human lymphocyte CEM cell line from HIV-1-mediated cytotoxicity","volume":"15","author":"Nozaki-Renard","year":"1990","journal-title":"Cell Struct Funct"},{"issue":"4","key":"10.1016\/j.mehy.2018.05.004_b0030","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s10096-014-2296-3","article-title":"Antiviral, antifungal, and antiparasitic activities of fluoroquinolones optimized for treatment of bacterial infections: a puzzling paradox or a logical consequence of their mode of action?","volume":"34","author":"Dalhoff","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.mehy.2018.05.004_b0035","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0166-3542(87)90064-7","article-title":"Antiviral activity and inhibition of topoisomerase by ofloxacin, a new quinolone derivative","volume":"8","author":"Ikeda","year":"1987","journal-title":"Antiviral Res"},{"issue":"3","key":"10.1016\/j.mehy.2018.05.004_b0040","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3851\/IMP1937","article-title":"Fluoroquinolones inhibit HCV by targeting its helicase","volume":"17","author":"Khan","year":"2012","journal-title":"Antiviral Ther"},{"issue":"4","key":"10.1016\/j.mehy.2018.05.004_b0045","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1086\/427291","article-title":"Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation","volume":"40","author":"Leung","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.mehy.2018.05.004_b0050","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2174\/1568005043340920","article-title":"Antiviral properties of quinolone-based drugs","volume":"4","author":"Richter","year":"2004","journal-title":"Curr Drug Targets-Infect Dis"},{"issue":"1","key":"10.1016\/j.mehy.2018.05.004_b0055","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/1743-422X-10-274","article-title":"Possible antiviral effect of ciprofloxacin treatment on polyomavirus BK replication and analysis of non-coding control region sequences","volume":"10","author":"Umbro","year":"2013","journal-title":"Virol J"},{"issue":"8","key":"10.1016\/j.mehy.2018.05.004_b0060","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1128\/AAC.00259-12","article-title":"Levofloxacin inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells","volume":"56","author":"Yamaya","year":"2012","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987718303591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987718303591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T12:00:36Z","timestamp":1535112036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987718303591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":12,"alternative-id":["S0306987718303591"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2018.05.004","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two for one: Viral helicases as an ideal target for HIV and HCV co-infection","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2018.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}